Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medications
about
sameAs
Diagnosis and therapy of non-variceal upper gastrointestinal bleedingPantoprazole for the treatment of peptic ulcer bleeding and prevention of rebleedingA nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug useSelective serotonin re-uptake inhibitors and the risk of bleedingAn international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk.One fifth of hospitalizations for peptic ulcer-related bleeding are potentially preventable.Etiology and outcome of patients with upper gastrointestinal bleeding: a study from South of Iran.Restrictive vs liberal transfusion for upper gastrointestinal bleeding: a meta-analysis of randomized controlled trials.Administration of erythromycin before endoscopy in upper gastrointestinal bleeding: a meta-analysis of randomized controlled trials.Prophylactic tracheal intubation for upper GI bleeding: A meta-analysisSupratherapeutic anticoagulation at presentation is associated with reduced mortality in nonvariceal upper gastrointestinal hemorrhageSecular trends in Helicobacter pylori seroprevalence in adults in the United States: evidence for sustained race/ethnic disparities.Trends in Peptic Ulcer Disease and the Identification of Helicobacter Pylori as a Causative Organism: Population-based Estimates from the US Nationwide Inpatient Sample.Trends in hospitalizations for peptic ulcer disease, United States, 1998-2005.Acute Myocardial Infarction Risk in Patients with Coronary Artery Disease Doubled after Upper Gastrointestinal Tract Bleeding: A Nationwide Nested Case-Control Study.Pre-endoscopic proton pump inhibitor therapy reduces recurrent adverse gastrointestinal outcomes in patients with acute non-variceal upper gastrointestinal bleeding.Pillcam ESO(®) is more accurate than clinical scoring systems in risk stratifying emergency room patients with acute upper gastrointestinal bleedingCLINICAL CHARACTERISTICS AND OUTCOME OF PATIENTS WITH UPPER GASTROINTESTINAL BLEEDING AT THE EMERGENCY DEPARTMENT OF A TERTIARY HOSPITAL IN NIGERIA.Clinical outcome of acute nonvariceal upper gastrointestinal bleeding after hours: the role of urgent endoscopy.The role of rapid endoscopy for high-risk patients with acute nonvariceal upper gastrointestinal bleeding.Comparison of AIMS65 Score and Other Scoring Systems for Predicting Clinical Outcomes in Koreans with Nonvariceal Upper Gastrointestinal Bleeding.Artificial Neural Networks for Early Prediction of Mortality in Patients with Non Variceal Upper GI Bleeding (UGIB)Comorbidities affect risk of nonvariceal upper gastrointestinal bleeding.Factors Associated with Outcome in Patients with Acute Upper Gastrointestinal Bleeding in a Tertiary Referral Center in Northern Iran.Application of endoscopic hemoclips for nonvariceal bleeding in the upper gastrointestinal tract.Seasonal Variations and Trends in Hospitalization for Peptic Ulcer Disease in the United States: A 12-Year Analysis of the Nationwide Inpatient SampleSystematic review of peptic ulcer disease incidence rates: do studies without validation provide reliable estimates?Acid peptic diseases: pharmacological approach to treatment.Management of non-variceal upper gastrointestinal tract hemorrhage: controversies and areas of uncertainty.Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: a systematic review and meta-analysis.Role of hemostatic powders in the endoscopic management of gastrointestinal bleeding.Randomised clinical trial: oral vs. intravenous iron after upper gastrointestinal haemorrhage--a placebo-controlled study.Safety and tolerability of high-dose intravenous esomeprazole for prevention of peptic ulcer rebleeding.Factors at presentation predictive of a requirement for endoscopic therapy in patients presenting with overt upper gastrointestinal haemorrhage: a retrospective observational study.Gastric Ulcer Complications after the Introduction of Proton Pump Inhibitors into Clinical Routine: 20-Year Experience.The Predictive Value of Preendoscopic Risk Scores to Predict Adverse Outcomes in Emergency Department Patients With Upper Gastrointestinal Bleeding: A Systematic Review.Relevance of surgery in patients with non-variceal upper gastrointestinal bleeding.Incidence of upper gastrointestinal haemorrhage in Maori and New Zealand European ethnic groups, 2001-2010.Decreasing trend of upper gastrointestinal bleeding mortality risk over three decades.Increased short- and long-term mortality in 8146 hospitalised peptic ulcer patients.
P2860
Q26777626-255F66D8-FC29-4B04-B729-350445A90185Q27025841-3AD9BC87-1425-49C2-9D70-528088C013ACQ28186337-8460DEF2-A9D8-4512-A67E-F9DD0FD56320Q28211440-8481C44C-B5AD-4A8E-9EFF-F0ED296974FBQ33925329-C273A428-BD45-4BDB-8DBB-C4D471710CB3Q34036732-18AC2A4B-09B2-4739-9EC6-422C50FB772EQ34368194-5746E879-F228-4299-988D-44C370CBEC85Q34382299-A3BF42BE-9ACD-46B6-B723-A39B33EEA93BQ34656158-D763BA98-E7DB-4E06-8E27-D2119812B978Q35136542-96AA66F4-425A-408D-BF82-E73DB7EB2D45Q35579679-7F0D7628-5F7F-499B-87DC-57016C2754FEQ35629631-DD0BDBAF-5DE7-468D-99B1-52B234BD9A3FQ35647007-795E6718-EA10-4B08-ACE6-39ABFA5E609BQ35806487-DA2A6D12-8620-47F0-86AA-B11FDB68F0C0Q35830454-B1431A04-6113-4BBA-B1BC-2C6E489C87F9Q36609905-FD8539E6-244E-4B31-BBD0-6060A4131560Q36761888-5828B65C-7052-4952-ACC8-ADCF1138C59FQ36860812-5AF3754E-463A-4C52-86A5-08662DC91664Q36864433-48195033-3076-4393-B7B5-0EC91F0BF1B6Q36885475-6953DC1A-2490-4B40-A777-9F866908D711Q37066351-7A802902-2934-42AE-BF1A-FA8C77DF0BA0Q37090033-4B9BBDCF-1CA7-4BA7-AAB7-0549727F216DQ37182009-8CBD8EB5-FAE8-4E07-B7C8-1C038B5D2785Q37302506-41EBD2C6-DEF6-4D4E-AC2F-3C05D0383302Q37347355-BFF03D0A-1E41-433B-9161-4469CB743734Q37458835-0E258E6A-F1D6-43D3-91F5-01CD6CFFD562Q37882609-88A65AAD-79AD-4A06-8499-31A4EB376286Q37913063-365F4B0F-D38A-4687-9827-508EB8B8129BQ37999016-F7AADC54-9188-456D-8B45-6B436C0527D8Q38207875-A6979A88-2552-429C-B152-D6F74DF47034Q38240880-BB63FF31-D6B4-461F-9EDE-CFA76E9F6B69Q38440965-781932C0-DCDF-469E-9329-287D22C2CBDFQ38496549-B27D8F65-2E68-4A2F-AE54-7747966FC4BCQ38609067-329A2115-C9CF-4AD4-848F-AB8D47518A6CQ38635760-188B2737-90DD-4D98-8138-91111B05F9FFQ38801731-73484DBB-F21E-4CA7-9877-F5D49F390ABDQ39018813-56FC9803-BC8B-43F0-8BBF-592A232D50B2Q39181259-F85A0AFE-0BCC-495A-A722-EF15F630A687Q39390614-1B49AEA1-B367-4EDF-B4C5-CDDBB5F6E3E0Q39725436-53749122-8649-4C2F-BDBB-AE7022BE7B7F
P2860
Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medications
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Hospitalization and mortality ...... d acid suppression medications
@ast
Hospitalization and mortality ...... d acid suppression medications
@en
Hospitalization and mortality ...... d acid suppression medications
@nl
type
label
Hospitalization and mortality ...... d acid suppression medications
@ast
Hospitalization and mortality ...... d acid suppression medications
@en
Hospitalization and mortality ...... d acid suppression medications
@nl
prefLabel
Hospitalization and mortality ...... d acid suppression medications
@ast
Hospitalization and mortality ...... d acid suppression medications
@en
Hospitalization and mortality ...... d acid suppression medications
@nl
P2093
P2860
P1476
Hospitalization and mortality ...... d acid suppression medications
@en
P2093
Brian L Strom
Colleen Brensinger
James D Lewis
John T Farrar
Warren B Bilker
P2860
P304
P356
10.1016/S0002-9270(02)04395-2
10.1111/J.1572-0241.2002.06037.X
P407
P577
2002-10-01T00:00:00Z